Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Role for alpha-L-fucosidase in the control of Helicobacter pylori-infected gastric cancer cells.

Liu TW, Ho CW, Huang HH, Chang SM, Popat SD, Wang YT, Wu MS, Chen YJ, Lin CH.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14581-6. doi: 10.1073/pnas.0903286106. Epub 2009 Aug 7.

2.

Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus.

Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer TF.

Cell Microbiol. 2000 Apr;2(2):155-64.

PMID:
11207572
3.

Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2.

Shabelnik MY, Kostyuk OV, Merentsev SV, Tarasova TO, Sidorenko SP.

Exp Oncol. 2009 Sep;31(3):134-9.

PMID:
19783969
4.
5.
6.

The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.

Arnold IC, Hitzler I, Engler D, Oertli M, Agger EM, Müller A.

J Immunol. 2011 Jun 1;186(11):6165-72. doi: 10.4049/jimmunol.1003472. Epub 2011 Apr 25.

7.

Evaluation of apoptosis induction using PARP cleavage on gastric adenocarcinoma and fibroblast cell lines by different strains of Helicobacter pylori.

Mojtahedi A, Salehi R, Navabakbar F, Tamizifar H, Tavakkoli H, Duronio V.

Pak J Biol Sci. 2007 Nov 15;10(22):4097-102.

PMID:
19090286
8.

Development of gastric cancer associated with Helicobacter pylori infection.

Sugiyama T.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S12-20.

PMID:
15309509
9.

Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion.

Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C.

J Exp Med. 2005 Nov 7;202(9):1235-47.

10.

Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer.

Backert S, Schwarz T, Miehlke S, Kirsch C, Sommer C, Kwok T, Gerhard M, Goebel UB, Lehn N, Koenig W, Meyer TF.

Infect Immun. 2004 Feb;72(2):1043-56.

11.

Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells.

Oldani A, Cormont M, Hofman V, Chiozzi V, Oregioni O, Canonici A, Sciullo A, Sommi P, Fabbri A, Ricci V, Boquet P.

PLoS Pathog. 2009 Oct;5(10):e1000603. doi: 10.1371/journal.ppat.1000603. Epub 2009 Oct 2.

12.

Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases.

Marques T, David L, Reis C, Nogueira A.

Pathol Res Pract. 2005;201(10):665-72. Epub 2005 Sep 26.

PMID:
16325508
13.

Helicobacter pylori infection and gastric cancer.

Sugiyama T, Asaka M.

Med Electron Microsc. 2004 Sep;37(3):149-57. Review.

PMID:
15449106
14.
15.

Inducible nitric oxide synthase expression in gastroduodenal diseases infected with Helicobacter pylori.

Son HJ, Rhee JC, Park DI, Kim YH, Rhee PL, Koh KC, Paik SW, Choi KW, Kim JJ.

Helicobacter. 2001 Mar;6(1):37-43.

PMID:
11328364
16.

The genome-wide expression profile of gastric epithelial cells infected by naturally occurring cagA isogenic strains of Helicobacter pylori.

Sohn SH, Lee YC.

Environ Toxicol Pharmacol. 2011 Nov;32(3):382-9. doi: 10.1016/j.etap.2011.08.006. Epub 2011 Aug 16.

PMID:
22004957
17.

Lack of correlation between Lewis antigen expression by Helicobacter pylori and gastric epithelial cells in infected patients.

Taylor DE, Rasko DA, Sherburne R, Ho C, Jewell LD.

Gastroenterology. 1998 Nov;115(5):1113-22.

PMID:
9797366
18.

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States.

Miehlke S, Kibler K, Kim JG, Figura N, Small SM, Graham DY, Go MF.

Am J Gastroenterol. 1996 Jul;91(7):1322-5.

PMID:
8677987
19.
20.

Supplemental Content

Support Center